Panel: Developing a shared approach to implementing genomic newborn screening to transform the diagnostic and therapeutic odysseys of children with rare inheritable diseases Featuring RCIGM Chief Strategy & Innovation Officer Wendy Benson speaking about the BeginNGS project.

We welcome industry leaders to a reception during the World Orphan Drug Congress in Boston celebrating the launch of the BeginNGS consortium.

With the advances in genomic sequencing and its impact on the care we provide for our critically ill neonates in our intensive care units, there has been an increasing need for us to become as informed as possible with the lingo and implications. Please join us to discuss “Genomics and Health Equity” including the role of advocacy and current strategies to address/eliminate disparities. Faculty: Nathaly M. Sweeney, MD, MPH; Vence Bonham Jr., JD; Lily Lou, MD; Andrea Scheurer, MD; Jeffrey Horbar, MD A series of grand rounds presented in partnership with the Vermont-Oxford Network as part of the VON-Rady Children's Genomic Network

RCIGM Founder Stephen Kingsmore will present on "NICU Current State & Future of Whole Genome Sequencing" and receive a Luminary Award.

Speaker: Stephen Kingsmore, MD, DSc | President & CEO, Rady Children’s Institute for Genomic Medicine

RCIGM President & CEO Stephen Kingsmore will speak on a panel about newborn screening via rWGS.

Speaker: Charlotte Hobbs, MD, PhD | Chief Research and Clinical Management Officer, Rady Children’s Institute for Genomic Medicine

With the advances in genomic sequencing and its impact on the care we provide for our critically ill neonates in our intensive care units, there has been an increasing need for us to become as informed as possible with the lingo and implications. Please join us to discuss “Using Genomics Wisely” and the Ethical, Legal, and Social Issues surrounding personalized medicine. Faculty: Nathaly M. Sweeney, MD, MPH; John Zupancic, MD, MS, ScD; Ingrid Holm, MD, MPH; Russell Nofsinger, PhD; Jeffrey Horbar, MD

As part of the Newborn Screening workshop (8am-12pm), Dr. Kingsmore will present "Newborn Screening: Toward a System that Keeps Pace with Gene Therapy Advances" from 11:05-11:15am.

Dr. Stephen Kingsmore and Tiledb founder and CEO Stavros Papadopoulos will present "Scaling Newborn Screening & Precision Medicine to 1 Million Babies" at this luncheon presentation.